Investigating the Neural Signature of Freezing of Gait in Parkinson's Disease
NCT ID: NCT06841718
Last Updated: 2025-02-24
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
ENROLLING_BY_INVITATION
28 participants
OBSERVATIONAL
2024-11-04
2026-09-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
This study will investigate the cortical signature of FOG using ambulatory electroencephalography (EEG) to help improve FOG detection algorithms and provide novel insights into the underlying pathophysiology, which together will guide therapy development.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Investigating Therapies for Freezing of Gait
NCT03065127
The Influence of Sensory Stimuli on Gait Imagery in Patients With Freezing of Gait
NCT01071590
Spinal Cord Stimulation for Freezing of Gait in Parkinson's Disease
NCT06798844
Freezing of Gait: Clinical, Cognitive, and Imaging Features
NCT02387281
EMG to Detect and Monitor Freezing of Gait Among People With Parkinson's Disease
NCT05693207
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Home assessment
All 28 participants will undergo a single home based assessment including a gait protocol as well as administering clinimetrics and questionnaires. Patients will be tested early in the morning after at least 12 hours without the anti-parkinsonian medication (= 'partial' OFF medication) and then about 1 hour after the intake of the first morning medication dose, when the subject reports reaching self-reported ON state (= ON medication). The gait protocol consist out of A) a trajectory in the participants home from the living room towards the bathroom and back, including a 360° turn as well as a figure-8 turn and going through a doorway and B) a daily living task. All tests will be conducted in a fixed order. The protocol will be conducted as a single task, with a dual task (serial subtraction task), with voluntary stops during different parts of the trajectory, and with an auditory cue (rhythm set 10% slower then typical cadence).
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
2. Modified Hoehn \& Yahr (H\&Y) Stage I to IV in the ON medication state
3. Age above 18 years\*
4. Able to walk 5 minutes while unassisted by a walker or another person (the use of a cane is allowed).\*
5. Mini Mental State Examination\>= 21
6. At least three hours in-between regular medication intakes to allow for stable testing time.\*
7. Self-reported FOG with a severity of at least 1 FOG episode per day, based on items 1 and 2 of the New Freezing of Gait Questionnaire, irrespective of FOG occurring ON- or OFF-medication.\*
8. Stable medication scheme for at least 7 days before enrollment.
Exclusion Criteria
2. Acute musculoskeletal or other neurological, psychiatric, or cardiovascular conditions affecting gait or any other medical condition which, in the opinion of the investigator, may prevent the participant from completing the protocol in full
3. Unable to adhere to assessment procedures leading to missing or unusable data, as determined by the investigators
4. Not a stable medication scheme for at least 7 days before the assessment.\*
5. Occurrence of any of the following within 3 months prior to informed consent:
* Orthopedic surgery of the lower extremity
* Myocardial infarction
* Hospitalization for unstable angina
* Coronary artery bypass graft
* Percutaneous coronary intervention
* Implantation of a cardiac resynchronization therapy device
* Implantation of deep brain stimulation
6. Substance abuse that may interfere with the patient's compliance
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
KU Leuven
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Moran Gilat
Professor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Moran Gilat, PhD
Role: PRINCIPAL_INVESTIGATOR
KU Leuven
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Department of rehabilitation sciences
Leuven, , Belgium
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
s69013
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.